Cazenove loses two pharmaceutical analysts

Pharmaceutical analysts David Crawley and Alistair Campbell have left Cazenove to join Schroder Salomon Smith Barney (SSSB).

The two hires now bring to seven SSSB's total number of analysts in its European pharmaceutical and healthcare team.

WSJ Logo
Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a BillionaireExternal link

Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a Billionaire